Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| 2011/0244018 |
DECONTAMINANT EDIBLE PRODUCT, METHODS OF PRODUCTION AND USES THEREOF The invention relates to an edible product containing a decontaminant. Particularly, the invention relates to an edible product, for instance, a food-like... |
| 2011/0244017 |
Absorbable Coating For Implantable Device The present invention provides an absorbable coating for an implantable device and the methods of making and using the same. |
| 2011/0244016 |
MEDICAL IMPLANT HAVING A COATING COMPOSED OF OR CONTAINING AT LEAST ONE
ACTIVE SUBSTANCE One embodiment of the invention relates to a medical implant whose surface is completely or partially covered by a coating composed of at least one active... |
| 2011/0244015 |
IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE
THEREOF This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active octreotide at a constant rate for an... |
| 2011/0244014 |
IMPLANTABLE MEDICAL ARTICLES HAVING LAMININ COATINGS AND METHODS OF USE Laminin-containing coatings for the surfaces of implantable medical devices are disclosed. The coatings promote the formation of vessels in association with the... |
| 2011/0244013 |
MICROPOROUS MATERIAL FROM ETHYLENE-CHLOROTRIFLUOROETHYLENE COPOLYMER AND
METHOD FOR MAKING SAME Microporous material having a spherulitic matrix made from ethylene chlorotrifluoroethylene copolymer has a plurality of pores having an average pore size... |
| 2011/0244012 |
FUNGICIDE, PHOTO CATALYTIC COMPOSITE MATERIAL, ADSORBENT, AND DEPURATIVE Disclosed herein is a fungicide, including: a porous carbon material; and a silver member adhered to the porous carbon material, wherein a value of a specific... |
| 2011/0244011 |
SPECIFIC DELIVERY OF AGROCHEMICALS The present invention relates to specific delivery of agrochemicals to plants. More specifically, it relates to a composition, essentially consisting of a... |
| 2011/0244010 |
Medical devices including medicaments and methods of making and using same The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using... |
| 2011/0244009 |
Children's Hygiene Products Shaped Like Sports Balls A child's hygienic product comprises a body of hygiene material having an exterior surface simulating a sports ball that is sized to fit the palm of a child's... |
| 2011/0244008 |
COSMETIC COMPOSITION A cosmetic composition having an excellent ultraviolet and infrared protection function, a greatly improved feeling of use and high product stability such as... |
| 2011/0244007 |
SPHERICAL COMPOSITE PARTICLES AND METHOD FOR MANUFACTURING THE SAME Disclosed are a method for manufacturing spherical composite particles, by which desired functions are simply and efficiently imparted to the surface or inside... |
| 2011/0244006 |
MICROSPHERE SKIN TREATMENT This application provides a microsphere suitable for tissue engineering that comprises connective tissue growth factor (CTGF). Also provided is a matrix,... |
| 2011/0244005 |
CONTROLLED RELEASE CGRP DELIVERY COMPOSITION FOR CARDIOVASCULAR AND RENAL
INDICATIONS The present invention provides methods of treating heart failure and improving renal function, and/or preventing the advancement of heart failure into advanced... |
| 2011/0244004 |
ANTIFUNGAL COMPOSITION WITH ENHANCED BIOAVAILABILITY A liquid suspension comprising an antifungally effective amount of the micronized compound represented by the chemical structural formula I: ##STR00001## at least... |
| 2011/0244003 |
Self Standing Nanoparticle Networks/Scaffolds with Controllable Void
Dimensions The present invention discloses a self standing network or scaffold of nanoparticles with controllably variable mesh size between 500 nm and 1 mm having... |
| 2011/0244002 |
MESOPOROUS MATERIAL EXCIPIENTS FOR POORLY AQUEOUS SOLUBLE INGREDIENTS The present invention encompasses formulations and methods for producing solid dispersions comprising mesoporous materials with poorly aqueous soluble active... |
| 2011/0244001 |
System and method for the release of nitric oxide using nanoscale media A composite material containing polymeric nanofibers, themselves containing NO-donor molecules, imbibed with an elastomer matrix is permeable to both water and... |
| 2011/0244000 |
ANTIMICROBIAL FILM LAMINATE ASSEMBLIES AND METHODS OF USING AND
MANUFACTURING THE SAME An antimicrobial film laminate assembly is disclosed. The assembly includes an antimicrobial film laminate having a first surface at least partially coated with... |
| 2011/0243999 |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS The invention provides methods and compositions for the delivery of lipophilic drugs that are useful for the treatment of various ophthalmological diseases,... |
| 2011/0243998 |
PATCH PREPARATION AND PRODUCTION METHOD THEREOF The invention provides a patch preparation containing (a) a support and (b) an adhesive layer containing a drug on the surface of the support, wherein a crystal... |
| 2011/0243997 |
FILM-FORM PREPARATION AND METHOD FOR PRODUCING THE SAME The present invention provides a film-form preparation having a rapid dissolution profile in the mouth and sufficient film strength, and also having excellent... |
| 2011/0243996 |
Spray freeze dry of compositions for intranasal administration This invention provides methods and compositions to preserve bioactive materials, such as peptides, nucleic acids, viruses, bacteria, cells, or liposomes, in... |
| 2011/0243995 |
Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and
Correspondingly Mutated MDM2-Protein... The invention relates to the rational mutagenesis of polypeptides of .alpha./.beta. T-cell receptors that mediate an oncogen-specific T-cell response, nucleic... |
| 2011/0243994 |
STABILIZED PHARMACEUTICAL COMPOSITION, LIQUID PREPARATION OF STABILIZED
PHARMACEUTICAL COMPOSITION, FILM-FORM... The present invention provides a stabilized pharmaceutical composition that enables the production of a preparation for desensitization therapy useful as an... |
| 2011/0243993 |
Method for diagnosing and creating immunogenic tolerance in contact
allergy and other epithelial... A method is provided for diagnosis and induction of immunogenic tolerance in contact allergy and other epithelial immunotoxicological ailments, based on... |
| 2011/0243992 |
METHODS OF ENHANCING THE IMMUNOGENICITY OF MYCOBACTERIA AND COMPOSITIONS
FOR THE TREATMENT OF CANCER,... Whole-cell vaccines and methods for enhancing the immunogenicity of cellular microorganisms for use in producing protective immune responses in vertebrate hosts... |
| 2011/0243991 |
PROCESS FOR PRODUCTION OF VACCINES The invention relates to a process for the production of a vaccine against bacterial pathogens which produce an AB toxin, like Clostridium, comprising (a)... |
| 2011/0243990 |
Vaccine comprising lactobacilli for treating prostate inflammation and
benign prostate hyperplasias The invention relates to vaccines for treating prostate inflammation and benign prostate hyperplasias (stages I and II) comprising Lactobacillus strains in an... |
| 2011/0243989 |
IDNA VACCINES AND METHODS FOR USING THE SAME Described herein are iDNA vectors and vaccines and methods for using the same. The iDNA generates live attenuated vaccines in eukaryotic cells in vitro or in... |
| 2011/0243988 |
Methods and Compositions for Stabilization of a Virus Vaccine This invention provides compositions and methods for stabilizing a live attenuated virus in dried formulations. In particular, compositions and methods of... |
| 2011/0243987 |
INFLUENZA VACCINE The present invention relates to monovalent influenza vaccine formulations and vaccination regimes for immunising against influenza disease, their use in... |
| 2011/0243986 |
POLYNUCLEOTIDES ALLOWING THE EXPRESSION AND SECRETION OF RECOMBINANT
PSEUDO-VIRUS CONTAINING FOREIGN EPITOPES,... This invention provides a new approach to the design of a virus with a defective replication cycle, which can be rescued by wild type virus co-infection, and... |
| 2011/0243985 |
SELF-ADHESIVE MATRIX SYSTEM COMPRISING A STYRENE BLOCK COPOLYMER Disclosed is a self-adhesive matrix system comprising a styrene-ethylene/butylene-styrene (SEBS) copolymer in an oil/ethyl acetate mixture, a hydrogenated resin... |
| 2011/0243984 |
COMPOSITION FOR TREATMENT OF DIABETES MELLITUS AND A PREPARATION AND AN
USE THEREOF The present invention relates to a composition for treating diabetes and a preparation method thereof as well as use thereof. The present invention provides a... |
| 2011/0243983 |
COSMETIC USE OF SKIN CELL AUTOPHAGY ACTIVATORS The object of the invention is the use in a cosmetic composition of an effective amount of at least one cutaneous cell autophagy activator as a cosmetic active... |
| 2011/0243982 |
Chimeric MSP-Based Malaria Vaccine The invention provides an immunogenic composition comprising MSP-8 linked to an antigen. Methods of using the composition to induce an immune response in an... |
| 2011/0243981 |
THERAPEUTIC MYELIN SHEATH DERIVED ANTAGONIST PEPTIDE CONJUGATES A first aspect of the invention relates to a conjugate comprising: (i) mannan; and (ii) at least one epitope comprising a peptide fragment of a protein selected... |
| 2011/0243980 |
METHODS AND SYSTEMS FOR O-GLYCOSYLATING PROTEINS Described herein are methods and systems for O-glycosylating proteins in vivo or in vitro in any prokaryotic organism. In these methods and systems, DNA... |
| 2011/0243979 |
Method of Transcutaneous Immunization Using Antigen Transcutaneous immunization can deliver antigen to the immune system through the stratum corneum without physical or chemical penetration to the dermis layer of... |
| 2011/0243978 |
ENTEROCOCCUS ANTIGENS The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum... |
| 2011/0243977 |
SURFACE PROTEINS OF STREPTOCOCCUS PYOGENES .beta.-hemolytic streptococci polynucleotides, polypeptides, particularly Streptococcus pyogenes polypeptides and polynucleotides, and antibodies of these... |
| 2011/0243976 |
COMPOSITIONS COMPRISING PNEUMOCOCCAL ANTIGENS Disclosed herein are various combinations of pneumococcal polypeptides for use in immunisation. Also disclosed herein are pneumococcal polypeptides that may be... |
| 2011/0243975 |
TRANSFORMED SOYBEAN PLANT WHICH ACCUMULATES VACCINE, AND USE THEREOF A transformed soybean plant having a gene encoding a modified seed storage protein introduced therein, obtained by inserting a gene encoding an Alzheimer's... |
| 2011/0243974 |
NOVEL TUMOR ANTIGEN PROTEIN SART-3 AND TUMOR ANTIGEN PEPTIDES THEREOF A novel tumor antigen protein and gene therefor, tumor antigen peptides derived from said tumor antigen protein or derivatives thereof as well as medicaments,... |
| 2011/0243973 |
HIG2 AND URLC10 EPITOPE PEPTIDE AND VACCINES CONTAINING THE SAME The present invention provides a pharmaceutical agent or composition containing one or more peptides having the amino acid sequence of SEQ ID NO: 1 or 2, or one... |
| 2011/0243972 |
PROSTATE STEM CELL ANTIGEN VACCINES AND USES THEREOF This invention relates to the identification of prostate stem cell antigen (PSCA) as a target of clinically relevant antitumor immune responses. The invention... |
| 2011/0243971 |
Vaccines The invention relates to a vaccine composition comprising an antigen, an immunologically active saponin fraction and a sterol. |
| 2011/0243970 |
COMPOSITION FOR INHIBITION OF TRANSPLANT REJECTION CONTAINING THE
CORDYCEPS MYCELLIA EXTRACT AS AN ACTIVE... Disclosed is a composition for the inhibition of transplant rejection and the treatment of skin diseases, comprising a cordyceps mycellia extract as an active... |
| 2011/0243969 |
PRODUCTION OF SQUALENE FROM HYPER-PRODUCING YEASTS A method for preparing purified yeast is disclosed, where the squalene source is a yeast that hyper-produces squalene. The squalene is useful for pharmaceutical... |
Copyright 2008−2013 Patents.com
